Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pharmacorp Rx Inc. ( (TSE:PCRX) ) just unveiled an announcement.
PharmaCorp Rx Inc. has announced a C$15 million bought deal public offering, involving the sale of 35.7 million units at C$0.42 per unit. The proceeds from this offering will be used for future acquisition opportunities and general working capital requirements, potentially strengthening the company’s market position and expanding its network of community pharmacies.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. is a Canadian pharmacy acquisition and ownership platform that focuses on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. The company is building a national network of community pharmacies under the PharmaChoice Canada banner, currently operating seven such pharmacies and planning to acquire more across Canada.
Average Trading Volume: 39,898
Technical Sentiment Signal: Sell
Current Market Cap: C$52.3M
See more insights into PCRX stock on TipRanks’ Stock Analysis page.